GEHC
GE HealthCare Technologies Inc. Healthcare - Medical Devices Investor Relations →
GE HealthCare Technologies Inc. (GEHC) closed at $68.02 as of 2026-07-31, trading 10.8% below its 200-week moving average of $76.28. This places GEHC in the extreme value zone. The stock moved further from the line this week, up from -20.6% last week. The 14-week RSI sits at 49, indicating neutral momentum.
Trading volume is running at 1.6x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.11 ratio) is neutral — neither side is clearly dominating.
Over the past 141 weeks of data, GEHC has crossed below its 200-week moving average 3 times. On average, these episodes lasted 19 weeks. Historically, investors who bought GEHC at the start of these episodes saw an average one-year return of +18.3%.
With a market cap of $30.7 billion, GEHC is a large-cap stock. The company generates a free cash flow yield of 5.1%, which is healthy. Return on equity stands at 19.4%, a solid level. The stock trades at 2.9x book value.
Over the past 2.8 years, a hypothetical investment of $100 in GEHC would have grown to $98, compared to $169 for the S&P 500. GEHC has returned -0.6% annualized vs 21.1% for the index, underperforming the broader market over this period.
In the past 12 months, corporate insiders have made 8 open-market purchases totaling $6,423,136. Multiple insiders purchased within a 30-day window — a cluster buy pattern that historically signals management confidence in the company's prospects. Notably, these purchases occurred while GEHC is trading below its 200-week moving average — insiders are buying when the market is most pessimistic.
Free cash flow has been declining at a -5.8% compound annual rate. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: GEHC vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After GEHC Crosses Below the Line?
Across 3 historical episodes, buying GEHC when it crossed below its 200-week moving average produced an average return of +18.5% after 12 months (median +20.0%), compared to +26.0% for the S&P 500 over the same periods. 100% of those episodes were profitable after one year. After 24 months, the average return was +16.0% vs +54.0% for the index.
Each line shows $100 invested at the moment GEHC crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Bean Score Experimental
The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices GEHC would reach each dislocation threshold.
Dislocation Price Levels
Prices where GEHC's Bean Score would hit each σ threshold. Valid until next earnings report (date TBD — last report: 2026-03-31).
| Level | σ | Price | Signal |
|---|---|---|---|
| Deep Value | +2σ | $58.32 | Unusually cheap — potential buy zone |
| Value | +1σ | $61.84 | Cheap vs. own history |
| Fair Value | +0σ | $65.81 | Historical mean behavior |
| Expensive | -1σ | $70.33 | Expensive vs. own history |
| Deep Expensive | -2σ | $75.51 | Unusually expensive — potential trim zone |
Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end
Signal Accuracy Collecting Data
The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"
Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are reference points for identifying potential swing trade opportunities, not buy/sell signals. FCF values update quarterly with earnings; between reports, all movement is price-driven.
Dislocation Scores Experimental
Each score measures deviation from GEHC's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.
Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. They are starting points for research, not buy or sell signals. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.
Historical Touches
GEHC has crossed below its 200-week MA 3 times with an average 1-year return of +18.3% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Nov 2023 | Dec 2023 | 2 | 5.5% | +20.1% | -1.5% |
| Mar 2025 | Nov 2025 | 34 | 23.0% | +16.5% | +12.7% |
| Mar 2026 | Ongoing | 22+ | 21.2% | Ongoing | -8.3% |
| Average | 19 | — | +18.3% | — |
Frequently Asked Questions
Is GEHC below its 200-week moving average?
Yes. As of 2026-07-31, GE HealthCare Technologies Inc. (GEHC) is trading 10.8% below its 200-week moving average of $76.28. The current price is $68.02.
What is GEHC's 200-week moving average price?
GE HealthCare Technologies Inc.'s 200-week moving average is $76.28 as of 2026-07-31. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when GEHC drops below its 200-week moving average?
GEHC has crossed below its 200-week moving average 3 times in our data. On average, buying at that moment produced a one-year return of +18.3%. These dips have historically been decent entry points. These episodes lasted 19 weeks on average.
Is GEHC a good value right now?
Here's what our data says about GEHC as of 2026-07-31: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 49. Free cash flow yield is 5.1%. Return on equity is 19.4%. Price-to-book is 2.9x. This is not a buy or sell recommendation — always do your own research.
How does GEHC compare to the S&P 500?
Over the past 2.8 years, $100 invested in GEHC would have grown to $98, compared to $169 for the S&P 500. That's -0.6% annualized vs 21.1% for the index. GEHC has underperformed the broader market over this period.
Does GEHC pay a dividend?
Yes. GE HealthCare Technologies Inc. currently pays a dividend yield of 20.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-07-31